Literature DB >> 7012027

Shigella sonnei phase I and phase II: susceptibility to direct serum lysis and opsonic requirements necessary for stimulation of leukocyte redox metabolism and killing.

G S Madonna, R C Allen.   

Abstract

The synthesis of the lipopolysaccharide O-specific repeat polymer by Shigella sonnei phase I is a clearly defined bacterial virulence factor necessary for penetrating epithelial cells; S. sonnei phase II does not synthesize this antigen and is uniformly avirulent. The serum opsonic requirements, relative to differences in gross lipopolysaccharide structure, were investigated by quantification and comparison of polymorphonuclear leukocyte (PMNL) metabolism and PMNL-mediated microbicidal action to phase I and phase II organisms, using normal and immune serum. The stimulation of PMNL O2-redox metabolism, as required for oxidative killing, was quantified by a chemiluminescent technique, using luminol as a chemilumigenic substrate. Susceptibility to direct serum or serum PMNL-mediated killing was evaluated by serum and serum-phagocytic killing assays. Stimulation of PMNL metabolism and phagocytic killing of S. sonnei phase I required opsonification by specific phase I antibody plus the classical pathway of complement. S. sonnei phase II was susceptible to direct complement-mediated serum killing. Likewise, opsonification of the phase II microbe, as measured by PMNL-associated chemiluminescence, was effected by complement in the absence of immune antibody. These data demonstrate the importance of the O-specific repeat polymer in protecting the microbe from the microbicidal action of PMNL and the bacteriolytic action of serum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012027      PMCID: PMC350600          DOI: 10.1128/iai.32.1.153-159.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.

Authors:  W P Reed
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM.

Authors:  J G HIRSCH; B STRAUSS
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

3.  Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages.

Authors:  R C Allen; L D Loose
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

4.  Evaluation of serum opsonic capacity by quantitating the initial chemiluminescent response from phagocytizing polymorphonuclear leukocytes.

Authors:  R C Allen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

5.  Shigellosis due to Shigella dysenteriae. 1. Relative importance of mucosal invasion versus toxin production in pathogenesis.

Authors:  P Gemski; A Takeuchi; O Washington; S B Formal
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

6.  Impaired chemiluminescence during phagocytosis of opsonized bacteria.

Authors:  R L Stjernholm; R C Allen; R H Steele; W W Waring; J A Harris
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

7.  Quantitative micro-complement fixation test.

Authors:  A A Marucci; T C Fuller
Journal:  Appl Microbiol       Date:  1971-02

Review 8.  Reduced, radical, and excited state oxygen in leukocyte microbicidal activity.

Authors:  R C Allen
Journal:  Front Biol       Date:  1979

9.  Absolute spectral sensitivity of phototubes and the application to the measurement of the absolute quantum yields of chemiluminescence and bioluminescence.

Authors:  J Lee; H H Seliger
Journal:  Photochem Photobiol       Date:  1965-12       Impact factor: 3.421

10.  Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen.

Authors:  D J Kopecko; O Washington; S B Formal
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

View more
  9 in total

1.  Kinetic analysis of microbe opsonification based on stimulated polymorphonuclear leukocyte oxygenation activity.

Authors:  R C Allen; M M Lieberman
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

2.  Comparative study of neutrophil activation by chemiluminescence and flow cytometry.

Authors:  M M Lieberman; D M Sachanandani; C A Pinney
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

3.  Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis.

Authors:  D Cohen; M S Green; C Block; R Slepon; I Ofek
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

4.  An Experimental Adult Zebrafish Model for Shigella Pathogenesis, Transmission, and Vaccine Efficacy Studies.

Authors:  Debaki R Howlader; Ushasi Bhaumik; Prolay Halder; Aishwarya Satpathy; Sounak Sarkar; Mrinalini Ghoshal; Suhrid Maiti; Jeffrey H Withey; Jiro Mitobe; Shanta Dutta; Hemanta Koley
Journal:  Microbiol Spectr       Date:  2022-05-23

5.  Activation of complement system by porins extracted from Salmonella typhimurium.

Authors:  F Galdiero; M A Tufano; L Sommese; A Folgore; F Tedesco
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

6.  Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp.

Authors:  E V Oaks; T L Hale; S B Formal
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

7.  Effects of anthrax toxin components on human neutrophils.

Authors:  J O'Brien; A Friedlander; T Dreier; J Ezzell; S Leppla
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

8.  The influence of riboflavin and nicotinic acid on Shigella sonnei colony conversion.

Authors:  Aa Deldar; B Yakhchali
Journal:  Iran J Microbiol       Date:  2011-03

9.  An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei.

Authors:  Mariaelena Caboni; Thierry Pédron; Omar Rossi; David Goulding; Derek Pickard; Francesco Citiulo; Calman A MacLennan; Gordon Dougan; Nicholas R Thomson; Allan Saul; Philippe J Sansonetti; Christiane Gerke
Journal:  PLoS Pathog       Date:  2015-03-20       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.